Earnings Winners And Losers: ABT, ISRG, JNJ, STJ
Among the first batch of companies to have released their latest quarterly earnings this week are medtech bellwethers Johnson & Johnson, Abbott, St. Jude Medical, Intuitive Surgical and Roche. Here are our picks of who we believe to be the winner, loser and one to watch from this batch.
You may also be interested in...
Abbott Labs' CEO Miles White expressed strong confidence in St. Jude and an unimpeded acquisition of the firm in the wake of continued cybersecurity allegations and a device-safety advisory.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.